Passa a Pro

🌟 Découvrez toutes nos offres sur desktop ou tablette !

Global Fecal Occult Testing Market Expected to Reach USD 3.89 Billion by 2031 as Colorectal Cancer Screening Expands Worldwide

[London, 5th, June 2025] – Clearview Market Insights (CVMI) forecasts that the global fecal occult testing (FOBT) market will grow from USD 1.93 billion in 2024 to USD 3.89 billion by 2031, reflecting a compound annual growth rate (CAGR) of 10.7 percent. This growth is driven by national colorectal cancer screening initiatives, the rising disease burden, and the increased adoption of fecal immunochemical tests (FIT).

"FOBT remains a cornerstone of non-invasive cancer screening, especially in population health programs. With innovations in home testing and automated analyzers, patient access and diagnostic efficiency are improving rapidly," said Dr. Elena Moretti, diagnostics analyst at CVMI.

Request Sample @ https://clearviewmarketinsights.com/report-details/global-fecal-occult-testing-market/

Key Numbers

  • 2024 Market Value: USD 1.93 billion
  • 2031 Market Value: USD 3.89 billion
  • Seven-Year CAGR: 10.7 percent
  • FIT Share (2024): 72%
  • North America Market Share: 41%

Market Drivers

  • Colorectal cancer as a global priority in non-communicable disease reduction
  • Home test kit adoption improving patient participation
  • FIT technology offering higher sensitivity and automation compatibility
  • Strong reimbursement support in U.S., Japan, and Australia

Company Highlights

  • QuidelOrtho launched QuickVue® FIT+ for consumer-friendly home use.
  • Sysmex secured public tenders across East Asia for high-throughput screening.
  • Polymedco expanded U.S. partnerships for large-scale FIT rollouts.
  • Eiken Chemical advanced its OC-Sensor line with new data connectivity modules.

Regional Highlights

  • North America: Mature reimbursement and clinical pathway integration.
  • Asia-Pacific: Expanding national CRC screening in Japan, South Korea, and Taiwan.
  • Europe: Strong public health campaigns with robust lab infrastructure.
  • LATAM & MEA: Public program pilots led by NGOs and multilateral health organizations.

2024–2025 Milestones

Quarter

Event

Outcome

Q1 2024

CMS updates screening coverage guidance

Expands coverage for high-risk populations under Medicare

Q2 2024

Polymedco wins multi-state FIT tender

Boosts access for Medicaid patients across U.S.

Q4 2024

Eiken launches OC-Sensor IoT kit

Enables real-time reporting to national health databases

Q1 2025

WHO issues FOBT framework for LMICs

Accelerates adoption in Southeast Asia and Africa

 

For more insights, visit https://clearviewmarketinsights.com/

 

About Clearview Market Insights

Clearview Market Insights is a diagnostics and public health research firm delivering actionable intelligence on over 100 medical screening, lab automation, and digital health markets. We specialize in evidence-backed forecasting to support public health policy and commercial strategy.

 

Media contact:

Bhavani K

Marketing and Sales Head

ClearView Market Insights

Mail: sales@clearviewmarketinsights.com

Phone: +1 917-993-7369

 

Babafig 🌍 https://www.babafig.com